. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies.

Enrico Maria Trecarichi, Mario Tumbarello, Teresa Spanu Pennestri, Morena Caira, Luana Fianchi, Patrizia Chiusolo, Giovanni Fadda, Giuseppe Leone, Roberto Cauda, Livio Pagano

Risultato della ricerca: Contributo in rivista › Articolo in rivista › peer review

Fingerprint

Entra nei temi di ricerca di '. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies.'. Insieme formano una fingerprint unica.

Medicine and Dentistry